Alzheimer's study to use brain amyloid PET scan

Jodelle Maglaya | | Health Imaging | Diagnostic Imaging

Palos Community Hospital in Illinois will participate in a national Alzheimer’s study which will use a certain type of PET scan to help detect protein plaques found in the brain that play a role in contributing to the disease.

The Imaging Dementia Evidence for Amyloid Scanning (IDEAS) study began in February 2016 and researchers are hoping to have 18,000 patients participate nationwide. If the researchers are able to rule out Alzheimer's with the PET scan, patients may be able to get better treatment of other kinds of dementia. 

The brain amyloid PET scan that is needed would cost $3,000 if not for this study. Medicare does not cover this type of scan and will only do so under the condition that the patient qualifies for the IDEAS study.

Read more here: 

Palos Community Hospital participates in Alzheimer's study

Jodelle Maglaya

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.